AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2019
May 13, 2019
284_dirs_2019-05-13_1c74284c-cc85-4ddc-a7d9-973f62ea0346.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2019-05-10
Reporting Person: Fleming Michael (SVP Chief Ethics & Com Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-05-10 | Common Stock | M | 1509.0000 | $0.0000 | Acquired | 3316.8290 | Direct |
| 2019-05-10 | Common Stock | F | 517.0000 | $78.3300 | Disposed | 2799.8290 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-05-10 | Restricted Stock Unit | $ | M | 1509.0000 | Disposed | 2019-05-10 | Common Stock (1509.0000) | Direct |
Footnotes
F1: Holdings include shares acquired in dividend reinvestment transactions.
F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8